UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential

British journal of cancer, 2020-05, Vol.122 (10), p.1428-1440

2020

Volltextzugriff (PDF)

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma

Nature communications, 2021-06, Vol.12 (1), p.3684-3684, Article 3684

2021

Volltextzugriff (PDF)

Cellular heterogeneity and plasticity in liver cancer

Seminars in cancer biology, 2022-07, Vol.82, p.134-149

2022

Volltextzugriff (PDF)

Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma

Hepatology (Baltimore, Md.), 2021-01, Vol.73 (1), p.23-40

2021

Volltextzugriff (PDF)

Joining the dots for better liver cancer treatment

Nature reviews. Gastroenterology & hepatology, 2020-02, Vol.17 (2), p.74

2020

Volltextzugriff (PDF)

Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2022-07, Vol.76 (1), p.48-65

2022

Volltextzugriff (PDF)

Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1

Cell & bioscience, 2021-12, Vol.11 (1), p.217-217, Article 217

2021

Volltextzugriff (PDF)

APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase‐independent activity

Molecular carcinogenesis, 2019-05, Vol.58 (5), p.643-653

2019

Volltextzugriff (PDF)

Asymmetric localization of DLC1 defines avian trunk neural crest polarity for directional delamination and migration

Nature communications, 2017-10, Vol.8 (1), p.1185-17, Article 1185

2017

Volltextzugriff (PDF)

Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function

PloS one, 2009-05, Vol.4 (5), p.e5572-e5572

2009

Volltextzugriff (PDF)

Investigation of Functional Synergism of CENPF and FOXM1 Identifies POLD1 as Downstream Target in Hepatocellular Carcinoma

Frontiers in medicine, 2022-07, Vol.9, p.860395-860395

2022

Volltextzugriff (PDF)

Akt Phosphorylation of Deleted in Liver Cancer 1 Abrogates Its Suppression of Liver Cancer Tumorigenesis and Metastasis

Gastroenterology (New York, N.Y. 1943), 2010-10, Vol.139 (4), p.1397-1407.e6

2010

Volltextzugriff (PDF)

Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma

PloS one, 2008-07, Vol.3 (7), p.e2779-e2779

2008

Volltextzugriff (PDF)

SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop

Gut, 2017-12, Vol.66 (12), p.2149

2017

Volltextzugriff (PDF)

Nuclear-targeted deleted in liver cancer 1 (DLC1) is less efficient in exerting its tumor suppressive activity both in vitro and in vivo

PloS one, 2011-09, Vol.6 (9), p.e25547-e25547

2011

Volltextzugriff (PDF)

Down‐regulation of TIMP2 by HIF‐1α/miR‐210/HIF‐3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2016-08, Vol.64 (2), p.473-487

2016

Volltextzugriff (PDF)

Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma

Journal of hepatology, 2022-08, Vol.77 (2), p.383-396

2022

Volltextzugriff (PDF)

RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma

Journal of hepatology, 2021-02, Vol.74 (2), p.360-371

2021

Volltextzugriff (PDF)

Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC

Hepatology (Baltimore, Md.), 2023-11, Vol.78 (5), p.1368-1383

2023

Volltextzugriff (PDF)

Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma

Liver international, 2010-01, Vol.30 (1), p.139-148

2010

Volltextzugriff (PDF)

Molecular Pathogenesis of Hepatocellular Carcinoma

Liver cancer (Basel ), 2016-10, Vol.5 (4), p.290-302

2016

Volltextzugriff (PDF)

Proteomic profiling in liver cancer: another new page

Translational gastroenterology and hepatology, 2019-06, Vol.4, p.47-47

2019

Volltextzugriff (PDF)

PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner

Cellular and molecular gastroenterology and hepatology, 2023-01, Vol.15 (6), p.1325-1350

2023

Volltextzugriff (PDF)

PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis

Nature communications, 2013, Vol.4 (1), p.1618, Article 1618

2013

Volltextzugriff (PDF)

Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma

Oncotarget, 2015-08, Vol.6 (25), p.20964-20976

2015

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(172)

Publikationsform

Sprache

Englisch
(184)
Japanisch
(21)
Chinesisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(109)
Humans
(87)
Female
(50)
Male
(46)
Adult
(37)
Middle Aged
(27)
Aged
(23)
Biological And Medical Sciences
(22)
Gastroenterology & Hepatology
(21)
Medical Sciences
(20)
Hepatocellular Carcinoma
(19)
Animals
(18)
Liver Cancer
(17)
Hong Kong
(16)
Patients
(16)
Carcinoma, Hepatocellular - Genetics
(14)
Cell Line, Tumor
(14)
Liver Neoplasms - Genetics
(14)
Tumors
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma

Cellular heterogeneity and plasticity in liver cancer

Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma

Joining the dots for better liver cancer treatment

Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma

Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1

APOBEC3B promotes hepatocarcinogenesis and metastasis through novel deaminase‐independent activity

Asymmetric localization of DLC1 defines avian trunk neural crest polarity for directional delamination and migration

Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function

Investigation of Functional Synergism of CENPF and FOXM1 Identifies POLD1 as Downstream Target in Hepatocellular Carcinoma

Akt Phosphorylation of Deleted in Liver Cancer 1 Abrogates Its Suppression of Liver Cancer Tumorigenesis and Metastasis

Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma

SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop

Nuclear-targeted deleted in liver cancer 1 (DLC1) is less efficient in exerting its tumor suppressive activity both in vitro and in vivo

Down‐regulation of TIMP2 by HIF‐1α/miR‐210/HIF‐3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma

Ephrin-A3/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma

RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma

Midline 1 interacting protein 1 promotes cancer metastasis through FOS-like 1-mediated matrix metalloproteinase 9 signaling in HCC

Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma

Molecular Pathogenesis of Hepatocellular Carcinoma

Proteomic profiling in liver cancer: another new page

PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner

PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis

Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma

Suchergebnisse filtern